Canaccord Genuity lowers Newell Brands stock price target on sales growth concerns

Canaccord Genuity lowered its price target on Newell Brands Inc. (NWL) to $9.00 from $11.00 but maintained a Buy rating, citing disappointing core sales guidance despite the company's achievement of eight consecutive quarters of significant gross margin expansion. The firm highlighted Newell's ongoing strategic shift to prioritize profitable brands and improve structural economics, encouraging investors to "buy this dip" due to asymmetric upside. This perspective is part of a broader mixed analyst sentiment, with some firms like UBS and Citi maintaining Neutral ratings while JPMorgan upgraded NWL to Overweight, reflecting varied views on the company's turnaround progress.

Analysis

Newell Brands (NWL) presents a classic turnaround scenario with conflicting fundamental signals, leading to a divided analyst outlook. While Canaccord Genuity reduced its price target to $9.00 from $11.00, it maintained a Buy rating, highlighting the core tension in the company's performance. The negative catalyst is a reversal in sales momentum, with first-half 2025 core sales declining 3.4% and a further 3% decline projected for the third quarter. This top-line weakness is the primary concern for more cautious firms like UBS and Citi, which hold Neutral ratings. Conversely, the bull case, supported by Canaccord and an upgrade to Overweight from JPMorgan, is anchored in significant operational improvements. Newell has delivered eight consecutive quarters of gross margin expansion, including a 680-basis-point increase on a two-year stack in Q2, demonstrating management's successful focus on profitability. This is driven by a strategic overhaul under CEO Chris Peterson, which involves rationalizing the portfolio from 80 to 55 master brands, with the top 25 now driving 90% of sales and profit. The market appears to be pricing in some optimism for this strategy, as the stock trades above its 52-week low with a positive year-to-date return of 7.3%.

Key Decisions for Investors

• Investors with a higher risk appetite may consider the 'buy the dip' thesis, focusing on the potential for asymmetric upside if the company's margin expansion and brand rationalization strategy successfully translate to a sales recovery.
• More cautious investors should scrutinize upcoming quarterly reports for evidence of a stabilization or return to growth in core sales, as persistent top-line weakness remains the primary risk cited by neutral-rated analysts.
• All investors should monitor gross margin performance as a key indicator, as sustained profitability gains are the central pillar of the current bull thesis and a crucial offset to sales challenges.